Sang-Sun Yoon

Title: Sang-Sun Yoon: Innovator in Lung Adenocarcinoma Research

Introduction

Sang-Sun Yoon is a prominent inventor based in Iksan-si, South Korea. He has made significant contributions to the field of medical research, particularly in the area of lung adenocarcinoma. His innovative work has led to the development of a specific epitope and antibody that can aid in the diagnosis and treatment of this type of cancer.

Latest Patents

Sang-Sun Yoon holds a patent for an invention titled "Epitope of CD66C specific to lung adenocarcinoma and antibody recognizing the same." This patent focuses on identifying the epitope of CD66c that is specific to lung adenocarcinoma. The invention also includes the development of antibodies that recognize this epitope, as well as cell lines that produce these antibodies. The applications of this invention are crucial for the diagnosis, prevention, and treatment of lung adenocarcinoma.

Career Highlights

Throughout his career, Sang-Sun Yoon has been associated with Dinona Inc., where he has been able to apply his research in a practical setting. His work has not only advanced scientific understanding but has also contributed to potential therapeutic solutions for patients suffering from lung adenocarcinoma.

Collaborations

Sang-Sun Yoon has collaborated with notable colleagues, including Hyung-Geun Song and Mi-Hyang Shin. These collaborations have further enriched his research and have led to advancements in the field of cancer treatment.

Conclusion

Sang-Sun Yoon's innovative contributions to lung adenocarcinoma research highlight the importance of targeted therapies in modern medicine. His work continues to pave the way for advancements in cancer diagnosis and treatment.